Arijit Sarkar 
Dealstreet

Khaitan & Co advises HDFC Bank on providing ₹500 crore financing to Maiva Pharma

The funds will be utilised for a greenfield project for manufacturing of sterile injectables.

Bar & Bench

HDFC Bank Limited has granted a Rupee facility aggregating to ₹500 crore, with a non-fund based sublimit in form of letter of credit facility to Maiva Lifesciences Private Limited and Maiva Pharma Private Limited.

Khaitan & Co advised HDFC Bank on this transaction.

The transaction team consisted of Arijit Sarkar (Partner), Chirag Gohil (Senior Associate), Siddhant Shetty (Senior Associate) and Charul Lunia (Associate).

Maiva Pharma

Starting operations in 1996, Maiva Pharma has two decades of experience in manufacturing Sterile Injectables. The company manufactures sterile solutions in vials and ampoules and has lyophilization capability as well.

The funds will be utilised for a greenfield project for manufacturing of sterile injectables. 

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

TVK member moves Madras High Court alleging bribery in selection of government advocates

Citizens entitled to protest; slogans like BJP 'murdabad’ and ‘Amit Shah murdabad' not ground for externment: Bombay HC

Gauhati High Court rejects man's citizenship claim despite 15 documents

Single incident of mother-in-law abusing daughter-in-law not cruelty under Section 498A IPC: Jharkhand HC

Madras High Court cancels appointment of 17 Personal Assistants to judges

SCROLL FOR NEXT